Announced Mon, 10 Nov · 17:11 IST

JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve un-audited financial ....

JHS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JHS Svendgaard Laboratories has informed BSE that its Board of Directors meeting, originally scheduled earlier, has been rescheduled to Friday, November 14, 2025. The Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The company's trading window remains closed from October 1, 2025, until 48 hours after the results are announced. No financial figures or business updates have been disclosed in this filing.

Likely market impact

This is a routine procedural intimation with no direct impact on stock price. Investors should watch for the actual results announcement on or after November 14, 2025, which could move the stock depending on performance versus expectations.